{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T16:59:48Z","timestamp":1785171588770,"version":"3.55.0"},"posted":{"date-parts":[[2026,5,22]]},"group-title":"In Review","reference-count":32,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,5,8]]},"abstract":"<title>Abstract<\/title>\n                <p>\n                  Background\n In resource-limited settings, febrile neutropenia (FN) is one of the common cause of morbidity and mortality among immunocompromised individuals particularly those undergoing chemotherapy for malignancies. The clinical diagnosis and management of disease is challenging, due to the diverse range of causative pathogens and overreliance on the traditional diagnostic techniques. TaqMan array card (TAC), a microfluidics-based technique that allows simultaneous and rapid detection of multiple pathogens with high sensitivity, addressing these diagnostic needs.\nObjective\n The aim of this study was to determine the role of TAC in improving pathogen identification in hospitalized patients with FN.\nMethods\n This cross-sectional study enrolled 156 FN patients admitted to Aga Khan University and Hospital, Karachi, Pakistan. To enhance pathogen detection, blood culture broths were used for microbial enrichment, improving sensitivity and reliability. Both blood cultures and TAC assays were performed on the collected broths. Enrichment strategies were employed to reduce the impact of PCR inhibitors and increase microbial biomass, thereby enhancing the diagnostic sensitivity of TAC.\nResults\n TAC identified a diverse range of pathogens compared with traditional blood culture. Of 156 study participants, 61 (39.1%) were culture-positive and at least one pathogen was detected in 50 of the 146 samples by TAC assay. The common pathogen detected by TAC was\n                  <italic>K. pneumonia<\/italic>\n                  followed by\n                  <italic>E. coli<\/italic>\n                  and\n                  <italic>S. aureus<\/italic>\n                  , and\n                  <italic>Candida<\/italic>\n                  species along with two viruses (Parvovirus B19 and HHV6). Kappa values of 0.319 for\n                  <italic>E. coli<\/italic>\n                  and 0.644 for\n                  <italic>K. pneumoniae<\/italic>\n                  , TAC demonstrated a moderate association with blood culture results. Moreover,\n                  <italic>K. pneumoniae<\/italic>\n                  ,\n                  <italic>E. coli<\/italic>\n                  , and\n                  <italic>P. aeruginosa<\/italic>\n                  and\n                  <italic>Candida<\/italic>\n                  species were significantly associated with increased mortality among FN patients.\nConclusion\n The findings of this study suggest that TAC improves pathogen detection with high sensitivity in FN patients. Incorporating TAC into clinical settings may facilitate early pathogen identification leading to better clinical outcomes. Multicenter studies are needed to validate these results and assess the effectiveness of TAC in broader clinical settings.\n                <\/p>","DOI":"10.21203\/rs.3.rs-9652919\/v1","type":"posted-content","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T13:55:41Z","timestamp":1779458141000},"source":"Crossref","is-referenced-by-count":0,"title":["Enhanced detection of sepsis pathogens in hospitalized febrile neutropenia patients using blood culture broths with TaqMan array card"],"prefix":"10.21203","author":[{"given":"Furqan","family":"Kabir","sequence":"first","affiliation":[{"name":"Aga Khan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hammad Afzal","family":"Kayani","sequence":"additional","affiliation":[{"name":"Shaheed Zulfiqar Ali Bhutto Institute of Science and Technology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dur e","family":"Shahwar","sequence":"additional","affiliation":[{"name":"Aga Khan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rufei","family":"Ma","sequence":"additional","affiliation":[{"name":"Qingdao University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Iqbal","sequence":"additional","affiliation":[{"name":"Aga Khan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akram","family":"Hussain","sequence":"additional","affiliation":[{"name":"Aga Khan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jawaid","family":"Hussain","sequence":"additional","affiliation":[{"name":"Aga Khan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adil","family":"Kalam","sequence":"additional","affiliation":[{"name":"Aga Khan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Aziz","sequence":"additional","affiliation":[{"name":"Aga Khan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sehrish","family":"Munir","sequence":"additional","affiliation":[{"name":"Aga Khan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farrukh","family":"Qazi","sequence":"additional","affiliation":[{"name":"Aga Khan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[{"name":"Qingdao University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Houpt","sequence":"additional","affiliation":[{"name":"University of Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erum","family":"Khan","sequence":"additional","affiliation":[{"name":"Aga Khan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junaid","family":"Iqbal","sequence":"additional","affiliation":[{"name":"Aga Khan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asad","family":"Ali","sequence":"additional","affiliation":[{"name":"Aga Khan University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"7","key":"ref1","first-page":"537","article-title":"Clinical prediction models for febrile neutropenia and its outcomes: a systematic review","volume":"33","author":"Sheehy J","year":"2025","unstructured":"Sheehy J, et al. Clinical prediction models for febrile neutropenia and its outcomes: a systematic review. Support Care Cancer. 2025;33(7):537.","journal-title":"Support Care Cancer"},{"issue":"8","key":"ref2","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.3390\/diagnostics12081800","article-title":"Diagnosis and management of febrile neutropenia in pediatric oncology patients\u2014a systematic review","volume":"12","author":"Boeriu E","year":"2022","unstructured":"Boeriu E, et al. Diagnosis and management of febrile neutropenia in pediatric oncology patients\u2014a systematic review. Diagnostics. 2022;12(8):1800.","journal-title":"Diagnostics"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"20499361221138346","DOI":"10.1177\/20499361221138346","article-title":"Approach to fever in patients with neutropenia: a review of diagnosis and management","volume":"9","author":"Keck JM","year":"2022","unstructured":"Keck JM, et al. Approach to fever in patients with neutropenia: a review of diagnosis and management. Therapeutic Adv Infect Disease. 2022;9:20499361221138346.","journal-title":"Therapeutic Adv Infect Disease"},{"key":"ref4","first-page":"20499361221138346","article-title":"Approach to fever in patients with neutropenia: a review of diagnosis and management","volume":"9","author":"Keck JM","year":"2022","unstructured":"Keck JM, et al. Approach to fever in patients with neutropenia: a review of diagnosis and management. Ther Adv Infect Dis. 2022;9:20499361221138346.","journal-title":"Ther Adv Infect Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"204993612211383","DOI":"10.1177\/20499361221138346","article-title":"Approach to fever in patients with neutropenia: a review of diagnosis and management","volume":"9","author":"Keck J","year":"2022","unstructured":"Keck J, et al. Approach to fever in patients with neutropenia: a review of diagnosis and management. Therapeutic Adv Infect Disease. 2022;9:204993612211383.","journal-title":"Therapeutic Adv Infect Disease"},{"issue":"10","key":"ref6","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms11102547","article-title":"Evaluation of Febrile Neutropenia in Hospitalized Patients with Neoplasia Undergoing Chemotherapy","volume":"11","author":"Bachlitzanaki M","year":"2023","unstructured":"Bachlitzanaki M et al. Evaluation of Febrile Neutropenia in Hospitalized Patients with Neoplasia Undergoing Chemotherapy. Microorganisms, 2023. 11(10).","journal-title":"Microorganisms"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"100682","DOI":"10.1016\/j.ijregi.2025.100682","article-title":"Febrile neutropenia in the Middle East and North Africa Region: trends, management, and outcomes (2000\u20132024)-A systematic review","volume":"16","author":"Assaad N","year":"2025","unstructured":"El Assaad N, et al. Febrile neutropenia in the Middle East and North Africa Region: trends, management, and outcomes (2000\u20132024)-A systematic review. IJID Reg. 2025;16:100682.","journal-title":"IJID Reg"},{"key":"ref8","first-page":"6","article-title":"Febrile neutropenia in pediatric cancer patients: Experience from a tertiary health care facility of Pakistan","author":"Alam M","year":"2014","unstructured":"Alam M, Fadoo Z. Febrile neutropenia in pediatric cancer patients: Experience from a tertiary health care facility of Pakistan. Pediatr Infect Disease, 2014. 6.","journal-title":"Pediatr Infect Disease"},{"issue":"4","key":"ref9","doi-asserted-by":"crossref","first-page":"166","DOI":"10.37018\/zptb7901","article-title":"Burden of febrile neutropenia in paediatric oncology: Experience from Children\u2019s Hospital Lahore Pakistan","volume":"14","author":"Ahmad A","year":"2020","unstructured":"Ahmad A, et al. Burden of febrile neutropenia in paediatric oncology: Experience from Children\u2019s Hospital Lahore Pakistan. J Fatima Jinnah Med Univ. 2020;14(4):166\u20139.","journal-title":"J Fatima Jinnah Med Univ"},{"issue":"02","key":"ref10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4236\/ojepi.2017.72014","article-title":"Applying Multinational Association of Supportive Care of cancer index score for identifying Febrile Neutropenia patients at high risk of complications at Tertiary Care Hospital, Pakistan","volume":"7","author":"Samoon Z","year":"2017","unstructured":"Samoon Z, et al. Applying Multinational Association of Supportive Care of cancer index score for identifying Febrile Neutropenia patients at high risk of complications at Tertiary Care Hospital, Pakistan. Open J Epidemiol. 2017;7(02):159.","journal-title":"Open J Epidemiol"},{"issue":"7","key":"ref11","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1128\/AAC.02561-14","article-title":"Cohort study of the impact of time to antibiotic administration on mortality in patients with febrile neutropenia","volume":"58","author":"Rosa RG","year":"2014","unstructured":"Rosa RG, Goldani LZ. Cohort study of the impact of time to antibiotic administration on mortality in patients with febrile neutropenia. Antimicrob Agents Chemother. 2014;58(7):3799\u2013803.","journal-title":"Antimicrob Agents Chemother"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"103028","DOI":"10.1016\/j.eclinm.2024.103028","article-title":"Rapid molecular assays versus blood culture for bloodstream infections: a systematic review and meta-analysis","volume":"79","author":"Rapszky GA","year":"2025","unstructured":"Rapszky GA, et al. Rapid molecular assays versus blood culture for bloodstream infections: a systematic review and meta-analysis. eClinicalMedicine. 2025;79:103028.","journal-title":"eClinicalMedicine"},{"issue":"8","key":"ref13","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.3390\/diagnostics15081044","article-title":"Impact of Multiplex PCR on Diagnosis of Bacterial and Fungal Infections and Choice of Appropriate Antimicrobial Therapy","volume":"15","author":"Serapide F","year":"2025","unstructured":"Serapide F, et al. Impact of Multiplex PCR on Diagnosis of Bacterial and Fungal Infections and Choice of Appropriate Antimicrobial Therapy. Diagnostics. 2025;15(8):1044.","journal-title":"Diagnostics"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4103\/2278-330X.202565","article-title":"Epedimiologic, clinical profile and factors affecting the outcome in febrile neutropenia","volume":"6","author":"Krishnamani K","year":"2017","unstructured":"Krishnamani K, et al. Epedimiologic, clinical profile and factors affecting the outcome in febrile neutropenia. South Asian J Cancer. 2017;6(1):25.","journal-title":"South Asian J Cancer"},{"issue":"Supplement4","key":"ref15","doi-asserted-by":"crossref","first-page":"S194","DOI":"10.1093\/cid\/ciaf514","article-title":"Multi-Pathogen Surveillance of Acute Febrile Illness in Nigeria Using TaqMan Array Cards: Implementation Successes and Lessons Learned From the SAFIAN Study","volume":"81","author":"Kim JH","year":"2025","unstructured":"Kim JH, et al. Multi-Pathogen Surveillance of Acute Febrile Illness in Nigeria Using TaqMan Array Cards: Implementation Successes and Lessons Learned From the SAFIAN Study. Clin Infect Dis. 2025;81(Supplement4):S194\u2013201.","journal-title":"Clin Infect Dis"},{"key":"ref16","author":"Ferdousi T","year":"2023","unstructured":"Ferdousi T et al. Role of TaqMan array card in determining causative organisms of acute febrile illness in hospitalized patients. Journal of Clinical Laboratory Analysis, 2023. 37(13\u201314): p. e24948."},{"issue":"7","key":"ref17","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1080\/21505594.2016.1185585","article-title":"Enhanced detection of respiratory pathogens with nanotrap particles","volume":"7","author":"Shafagati N","year":"2016","unstructured":"Shafagati N, et al. Enhanced detection of respiratory pathogens with nanotrap particles. Virulence. 2016;7(7):756\u201369.","journal-title":"Virulence"},{"issue":"8","key":"ref18","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S1473-3099(14)70808-4","article-title":"Development and assessment of molecular diagnostic tests for 15 enteropathogens causing childhood diarrhoea: a multicentre study","volume":"14","author":"Liu J","year":"2014","unstructured":"Liu J, et al. Development and assessment of molecular diagnostic tests for 15 enteropathogens causing childhood diarrhoea: a multicentre study. Lancet Infect Dis. 2014;14(8):716\u201324.","journal-title":"Lancet Infect Dis"},{"issue":"10051","key":"ref19","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/S0140-6736(16)31529-X","article-title":"Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study","volume":"388","author":"Liu J","year":"2016","unstructured":"Liu J, et al. Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study. Lancet. 2016;388(10051):1291\u2013301.","journal-title":"Lancet"},{"issue":"12","key":"ref20","doi-asserted-by":"crossref","first-page":"e1309","DOI":"10.1016\/S2214-109X(18)30349-8","article-title":"Use of quantitative molecular diagnostic methods to assess the aetiology, burden, and clinical characteristics of diarrhoea in children in low-resource settings: a reanalysis of the MAL-ED cohort study","volume":"6","author":"Platts-Mills JA","year":"2018","unstructured":"Platts-Mills JA, et al. Use of quantitative molecular diagnostic methods to assess the aetiology, burden, and clinical characteristics of diarrhoea in children in low-resource settings: a reanalysis of the MAL-ED cohort study. Lancet Glob Health. 2018;6(12):e1309\u201318.","journal-title":"Lancet Glob Health"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ijregi.2021.09.002","article-title":"Mortality-associated clinical risk factors in patients with febrile neutropenia: A retrospective study","volume":"1","author":"Sereeaphinan C","year":"2021","unstructured":"Sereeaphinan C, Kanchanasuwan S, Julamanee J. Mortality-associated clinical risk factors in patients with febrile neutropenia: A retrospective study. IJID Reg. 2021;1:5\u201311.","journal-title":"IJID Reg"},{"issue":"14","key":"ref22","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25147770","article-title":"From Molecular Mechanisms to Clinical Therapy: Understanding Sepsis-Induced Multiple Organ Dysfunction","volume":"25","author":"Srdi\u0107 T","year":"2024","unstructured":"Srdi\u0107 T et al. From Molecular Mechanisms to Clinical Therapy: Understanding Sepsis-Induced Multiple Organ Dysfunction. Int J Mol Sci, 2024. 25(14).","journal-title":"Int J Mol Sci"},{"issue":"5","key":"ref23","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15051611","article-title":"Systematic Review of the Short-Term versus Long-Term Duration of Antibiotic Management for Neutropenic Fever in Patients with Cancer","volume":"15","author":"Ishikawa K","year":"2023","unstructured":"Ishikawa K et al. Systematic Review of the Short-Term versus Long-Term Duration of Antibiotic Management for Neutropenic Fever in Patients with Cancer. Cancers (Basel), 2023. 15(5).","journal-title":"Cancers (Basel)"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1182\/blood-2024-198520","article-title":"Impact of Early Antibiotic De-Escalation on Mortality in Febrile Neutropenia in Patients with Hematologic Malignancy Receiving Treatment: A Meta-Analysis","volume":"144","author":"Chen Y-H","year":"2024","unstructured":"Chen Y-H, et al. Impact of Early Antibiotic De-Escalation on Mortality in Febrile Neutropenia in Patients with Hematologic Malignancy Receiving Treatment: A Meta-Analysis. Blood. 2024;144:3553.","journal-title":"Blood"},{"issue":"5","key":"ref25","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.31557\/APJCP.2019.20.5.1471","article-title":"Bacterial Spectrum and Antimicrobial Resistance Pattern in Cancer Patients with Febrile Neutropenia","volume":"20","author":"Vahedian-Ardakani HA","year":"2019","unstructured":"Vahedian-Ardakani HA, et al. Bacterial Spectrum and Antimicrobial Resistance Pattern in Cancer Patients with Febrile Neutropenia. Asian Pac J Cancer Prev. 2019;20(5):1471\u20134.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1186\/s12879-017-2597-0","article-title":"Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study","volume":"17","author":"Kim HS","year":"2017","unstructured":"Kim HS, et al. Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study. BMC Infect Dis. 2017;17(1):500.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"ref27","doi-asserted-by":"publisher","first-page":"02494","DOI":"10.1128\/aac","article-title":"Clinical predictive model of multidrug resistance in neutropenic cancer patients with bloodstream infection due to Pseudomonas aeruginosa","volume":"64","author":"Gudiol C","year":"2020","unstructured":"Gudiol C, et al. Clinical predictive model of multidrug resistance in neutropenic cancer patients with bloodstream infection due to Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2020;64(4):02494\u201319. p. 10.1128\/aac.","journal-title":"Antimicrob Agents Chemother"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13756-016-0162-z","article-title":"Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005\u20132014","volume":"6","author":"Ahmed D","year":"2017","unstructured":"Ahmed D, et al. Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005\u20132014. Antimicrob Resist Infect Control. 2017;6:2.","journal-title":"Antimicrob Resist Infect Control"},{"key":"ref29","author":"Sarasombath T","year":"2026","unstructured":"Sarasombath T, Chaimayo C. Performance evaluation of TaqMan Array Card real-time PCR for multi-pathogen detection in acute undifierentiated febrile illness. 2026."},{"key":"ref30","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jviromet.2015.11.020","article-title":"Comparative analytical evaluation of the respiratory TaqMan Array Card with real-time PCR and commercial multi-pathogen assays","volume":"228","author":"Harvey JJ","year":"2016","unstructured":"Harvey JJ, et al. Comparative analytical evaluation of the respiratory TaqMan Array Card with real-time PCR and commercial multi-pathogen assays. J Virol Methods. 2016;228:151\u20137.","journal-title":"J Virol Methods"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"100906","DOI":"10.1016\/j.blre.2021.100906","article-title":"Diagnosis of infectious diseases in immunocompromised hosts using metagenomic next generation sequencing-based diagnostics","volume":"53","author":"Casto AM","year":"2022","unstructured":"Casto AM, Fredricks DN, Hill JA. Diagnosis of infectious diseases in immunocompromised hosts using metagenomic next generation sequencing-based diagnostics. Blood Rev. 2022;53:100906.","journal-title":"Blood Rev"},{"issue":"08","key":"ref32","doi-asserted-by":"crossref","first-page":"886","DOI":"10.3855\/jidc.12520","article-title":"Evaluation of risk factors for mortality in febrile neutropenia","volume":"14","author":"\u00c7eken S","year":"2020","unstructured":"\u00c7eken S, et al. Evaluation of risk factors for mortality in febrile neutropenia. J Infect Developing Ctries. 2020;14(08):886\u201392.","journal-title":"J Infect Developing Ctries"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9652919\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9652919\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T16:03:11Z","timestamp":1785168191000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9652919\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":32,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-9652919\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1186\/s12879-026-14004-z","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2026,5,22]]},"subtype":"preprint"}}